Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine

被引：4
作者：
Tomova, A.
Brodowicz, T.
Tzekova, V.
Timcheva, C.
Wiltschke, C.
Gerges, D. A.
Pawlega, J.
Spanik, S.
Inbar, M. J.
Zielinski, C. C.
机构：
[1] Plovdiv Canc Ctr, Plovdiv, Bulgaria
[2] Univ Vienna, Dept Med 1, Vienna, Austria
[3] Univ Hosp, Sofia, Bulgaria
[4] SBALO Natl Oncol Ctr, Sofia, Bulgaria
[5] Rizk Hosp, Beirut, Lebanon
[6] Klin Onkol CmuJ, Krakow, Poland
[7] Onkol Ustav Sv Alzbety, Bratislava, Slovakia
[8] Sourasky Med Ctr, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.1106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1106
引用
收藏
页数：1
相关论文
共 50 条
[41]   Gemcitabine plus docetaxel versus capecitabine plus docetaxel for patients with anthracycline-pretreated metastatic breast cancer: a review of the results of a European Phase III trial [J].
Chan, S .
EJC SUPPLEMENTS, 2005, 3 (05) :17-21
[42]   A phase III trial of Gemcitabine plus Docetaxel (GD) versus Capecitabine plus Docetaxel (CD) for patients (pt) with anthracycline-pretreated metastatic breast cancer [J].
Chan, S. ;
Sharma, R. ;
Romieu, G. ;
Huober, T. ;
Delozier, T. ;
Tubiana-Hulin, M. ;
Schneeweiss, A. ;
Lluch, A. ;
Llombart, A. ;
du Bois, A. ;
Carrasco, E. ;
Thareau, A. ;
Fumoleau, P. .
EJC SUPPLEMENTS, 2007, 5 (03) :15-16
[43]   Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine Followed by Gemcitabine and Capecitabine/Radiation Therapy and Surgery in Locally Advanced, Unresectable Pancreatic Adenocarcinoma [J].
Sherman, William H. ;
Chu, Kyung ;
Chabot, John ;
Allendorf, John ;
Schrope, Beth Ann ;
Hecht, Elizabeth ;
Jin, Brian ;
Leung, David ;
Remotti, Helen ;
Addeo, Gisella ;
Postolov, Inna ;
Tsai, Wei ;
Fine, Robert L. .
CANCER, 2015, 121 (05) :673-680
[44]   Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-Guerin [J].
Meeks, Joshua J. ;
Sexton, Wade J. ;
Clark, Peter E. .
JOURNAL OF UROLOGY, 2022, 208 (03) :526-527
[45]   A multicenter phase II randomized study of docetaxel (D)/gemcitabine (G) weekly followed by erlotinib (E) after progression versus erlotinib followed by docetaxel/gemcitabine after progression in advanced non-small cell lung cancer [J].
Le Caer, H. ;
Barlesi, F. ;
Corre, R. ;
Jullian, H. ;
Bota, S. ;
Falchero, L. ;
Vergnenegre, A. ;
Dujon, C. ;
Delhoume, J. Y. ;
Chouaid, C. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[46]   Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer [J].
Chan, Stephen ;
Romieu, Gilles ;
Huober, Jens ;
Delozier, Thierry ;
Tubiana-Hulin, Michele ;
Schneeweiss, Andreas ;
Lluch, Ana ;
Llombart, Antonio ;
du Bois, Andreas ;
Kreienberg, Rolf ;
Mayordomo, Jose Ignacio ;
Anton, Antonio ;
Harrison, Mark ;
Jones, Alison ;
Carrasco, Eva ;
Vaury, A. Thareau ;
Frimodt-Moller, Bente ;
Fumoleau, Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) :1753-1760
[47]   Docetaxel/gemcitabine/pembrolizumabVarious toxicities: case report [J].
Reactions Weekly, 2018, 1688 (1) :92-92
[48]   Examining gemcitabine and docetaxel for recurrent NMIBC. [J].
Milbar, Niv ;
Kates, Max ;
Chappidi, Meera ;
Schoenberg, Mark ;
Bivalacqua, Trinity J. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[49]   Gemcitabine combined with docetaxel in metastatic breast cancer [J].
Fumoleau, P .
SEMINARS IN ONCOLOGY, 2003, 30 (02) :15-18
[50]   Docetaxel/gemcitabine/paclitaxelLack of efficacy: case report [J].
Reactions Weekly, 2023, 1946 (1) :206-206
12345